drugset

drugset / Trial / NCT00367965

Study of Eszopiclone Compared to Placebo on Daytime Function in Subjects With Insomnia Related to Rheumatoid Arthritis

NCT00367965 ↗

Phase 3 Completed 153 enrolled Sumitomo Pharma America, Inc.

RandomizedParallel-groupTriple-blindTreatment

Summary

To demonstrate subjective sleep efficacy of eszopiclone 3 mg in subjects with insomnia related to rheumatoid arthritis (RA).

Timeline

Start: 2004-02
Primary completion: 2004-11
Completion: 2004-11

Publications

Roth T, Price JM, Amato DA, Rubens RP, Roach JM, Schnitzer TJ. The effect of eszopiclone in patients with insomnia and coexisting rheumatoid arthritis: a pilot study. Prim Care Companion J Clin Psychiatry. 2009;11(6):292-301. doi: 10.4088/PCC.08m00749bro.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Eszopiclone	Small molecule	3 mg	—

Indications